Status | Study |
Completed |
Study Name: Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial Condition: Childhood Infratentorial Ependymoma Childhood Supratentorial Date: 2011-07-30 Interventions: Other: laboratory biomarker analysis Correlative studies |
Recruiting |
Study Name: Carboplatin and Bevacizumab for Recurrent Ependymoma Condition: Ependymoma Anaplastic Ependymoma Date: 2011-02-11 Interventions: Drug: Carboplatin Carboplatin |
Terminated |
Study Name: Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205 Condition: Ependymoma Date: 2010-11-23 Interventions: Drug: Erlotinib continuous oral Erlotinib 85 mg/m^2 per day |
Recruiting |
Study Name: Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma Condition: Childhood Infratentorial Ependymoma Childhood Supratentorial Date: 2010-03-30 Interventions: Drug: liposomal vincristine sulfate |
Terminated |
Study Name: Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma Condition: Ependymoma Date: 2010-03-16 Interventions: Drug: Carboplatin Patients will receive daily carboplatin as a radiation sensitizer prior to radiation e |
Terminated |
Study Name: Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma Condition: Recurrent or Refractory Pediatric Ependymoma Date: 2009-12-10 Interventions: Drug: erlotinib oral |
Completed |
Study Name: Adult Intracranial Ependymoma Condition: Intracranial Ependymoma Date: 2009-05-04 Interventions: Other: tumoral sample Ependymoma tumoral sample |
Completed |
Study Name: Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma Condition: Brain Cancer Pediatric Cancers Date: 2009-04-17 Interventions: Drug: Bevacizumab 10 mg/kg giv |
Active, not recruiting |
Study Name: Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy Condition: Brain and Central Nervous System Tumors Cognitive/Functional Effects Date: 2008-05-21 Interventions: Drug: carboplatin Drug: cisplatin |
Completed |
Study Name: High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma Condition: Brain and Central Nervous System Tumors Date: 2006-02-06 Interventions: Drug: methotrexate Procedure: adjuvant the |